reglab/housing_qa huggingface dataset:
NJ Rev Stat § 24:6D-2 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6D-2 - Offenses

24:6D-2. Offenses  A person who: A. Counterfeits a trademark; or, B. Affixes to any drug, cosmetic or device a counterfeit trademark knowing the same to be counterfeit, or the genuine trademark of another, without the latter's consent; or, C. Knowingly sells, offers for sale, or possesses a drug, cosmetic or device to which is affixed a counterfeit trademark, or the genuine trademark of another, without the latter's consent; or, D. Has in his possession or conceals a counterfeit trademark, knowing it to be counterfeit, or a die, punch, plate, brand or other thing for the purpose of counterfeiting a trademark; or, for the purpose of making the genuine trademark of another without the latter's consent; or, E. Makes or sells, or offers to sell or dispose of, or has in his possession with intent to sell or dispose of, a drug, cosmetic or device with such a trademark or label as to appear to indicate the place of manufacture or production, or persons manufacturing, packing, bottling, boxing or producing the article, but not indicating it truly; or, F. Knowingly sells, offers or exposes for sale, or delivers any drug, cosmetic or device which is represented in any manner, by word or deed, to be the manufacture, packing, bottling, boxing or product of any person, firm or corporation, other than himself, without the consent of such other person, firm or corporation, unless such drug, cosmetic or device is contained in the original package, box or bottle and under the labels, marks or names placed thereon by the manufacturer or other person who is entitled to use such marks, names, brands or trademarks; or, G. Shall sell or shall expose for sale any drug, cosmetic or device in bulk, to which no label or trademark shall be attached, and shall by representation, name or mark written or printed thereon, represent that such drug, cosmetic or device is the production or manufacture of a person who is not the manufacturer; or, H. Shall knowingly sell, offer or expose for sale any drug, cosmetic or device, and shall orally or by representation, name or mark written or printed thereon or attached thereto used in connection therewith, or by advertisement, or otherwise, in any manner, whatsoever make any false representation as to the person by whom such drug, cosmetic or device or the material thereof was made, or was in whole or in part produced, manufactured, finished, processed, treated, marketed, packed, bottled, or boxed or falsely represents that such drug, cosmetic or device or the material or any part thereof has or may properly have any trademark attached to it or used in connection with it, or is or may properly be indicated or identified by any trademark. Is guilty of a high misdemeanor if the offense is committed with regard to a drug and is guilty of a misdemeanor if the offense is committed with respect to a cosmetic or device. L.1967, c. 311, s. 2, eff. Feb. 27, 1968.
NJ Rev Stat § 24:6D-3 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6D-3 - Enforcement

24:6D-3. Enforcement  A. It is hereby made the duty of the State Department of Health, its officers, agents, inspectors and representatives, and of all peace officers within the State, and of all county prosecutors, to enforce all provisions of this chapter, and to cooperate with all agencies charged with the enforcement of the laws of the United States, of this State, and of all other States, relating to counterfeiting of trademarks used in connection with drugs, cosmetics or devices. B. The commissioner and any officer or employee of the department designated by the commissioner to conduct investigations or engage in other enforcement activities relating to the counterfeiting of drugs, cosmetics or devices shall have the power to execute and serve search warrants and shall have the power of arrest in cases of violation of this chapter, and may, in the discharge of their duties, call in the aid of a constable, sheriff, or other peace officer when deemed necessary. L.1967, c. 311, s. 3, eff. Feb. 27, 1968.
NJ Rev Stat § 24:6E-1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-1 - Short title

24:6E-1. Short title  This act shall be known and may be cited as the "Prescription Drug Price and Quality Stabilization Act." L.1977, c. 240, s. 1, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-2 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-2 - Advertisement of prescription drugs; rules and regulations

24:6E-2. Advertisement of prescription drugs; rules and regulations  In conformance with the Administrative Procedure Act, P.L.1968, c. 410 (C. 52:14B-1 et seq.), the Director of the Division of Consumer Affairs shall promulgate rules and regulations governing the advertising of prescription drugs. Such rules and regulations shall include, but shall not be limited to, the following: (1) provisions governing the content of advertisements, including price quotations in conformance with usual and customary prescription amounts, dosage form, and services offered; (2) provisions prohibiting reference to the quality of a drug or its beneficial use; (3) provisions prohibiting the advertising for sale of a prescription drug at a retail price below the acquisition cost of the drug to the retail seller; (4) provisions governing the mandatory dissemination over the telephone of price information. Such rules and regulations shall be consistent, insofar as practicable, with Federal laws and regulations concerning advertising of prescription drugs, and the director may make any such Federal law or regulation applicable to the advertising of prescription drugs within this State by rule or regulation. L.1977, c. 240, s. 3, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-3 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-3 - Restraint on prescription drug price information to public

24:6E-3. Restraint on prescription drug price information to public  It shall be unlawful for any individual, group or association to restrain, directly or indirectly, the flow of prescription drug price information to the public. L.1977, c. 240, s. 4, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-7 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-7 - Prescriptions; dispensation of lowest cost interchangeable drug product; exceptions; notice of substitution

24:6E-7. Prescriptions; dispensation of lowest cost interchangeable drug product; exceptions; notice of substitution  Every prescription blank shall be imprinted with the words, "substitution permissible" and "do not substitute" and shall contain space for the physician's or other authorized prescriber's initials next to the chosen option. Notwithstanding any other law, unless the physician or other authorized prescriber explicitly states that there shall be no substitution when transmitting an oral prescription or, in the case of a written prescription, indicates that there shall be no substitution by initialing the prescription blank next to "do not substitute," a different brand name or nonbrand name drug product of the same established name shall be dispensed by a pharmacist if such different brand name or nonbrand name drug product shall reflect a lower cost to the consumer and is contained in the latest list of interchangeable drug products published by the council; provided, however, where the prescriber indicates "substitution permissible, and requests the pharmacist to notify him of the substitution," the pharmacist shall transmit notice, either orally or by written notice to be mailed no later than the end of the business day, to the prescriber specifying the drug product actually dispensed and the name of the manufacturer thereof. However, no drug interchange shall be made unless a savings to the consumer results, and the pharmacist passes such savings on to the consumer in full by charging no more than the regular and customary retail price for the drug to be substituted. For prescriptions filled other than by mail, the consumer may, if a substitution is indicated and prior to having his prescription filled, request the pharmacist or his agent to inform him of the price savings that would result from substitution. If the consumer is not satisfied with said price savings he may, upon request, be dispensed the drug product prescribed by the physician. The pharmacist shall make a notation of such request upon the prescription blank. L.1977, c. 240, s. 8, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-8 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-8 - Prescriptions; dispensation of substitute drug for drug not on latest list of interchangeable drug products; reasons; approval of prescriber

24:6E-8. Prescriptions; dispensation of substitute drug for drug not on latest list of interchangeable drug products; reasons; approval of prescriber  Notwithstanding any other law, where a different brand name or nonbrand name drug product of the same established name shall reflect a lower cost to the consumer and no drug product of such established name is included in the latest list of interchangeable drug products published by the council, or where in the professional judgment of the pharmacist there is no valid proof of efficacy for the drug product prescribed, or the pharmacist's patient profile record discloses drug sensitivity, allergies or adverse reactions to the drug product prescribed, or there exists a more appropriate drug product than the drug product prescribed, a different brand name or nonbrand name drug product shall be dispensed by the pharmacist, provided, however, that such action by a pharmacist shall be authorized only if in each case the pharmacist notifies the prescriber of the drug product to be dispensed and the name of the manufacturer thereof, and receives the approval of the prescriber to substitute such drug product for the drug product prescribed. The pharmacist shall be required to indicate on the prescription the date and time of the prescriber's approval and whether the approval was communicated orally or in writing. L.1977, c. 240, s. 9, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-9 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-9 - Dispensation of nonbrand name drug product; label.

24:6E-9 Dispensation of nonbrand name drug product; label.  10. If a nonbrand name drug product is dispensed, the pharmacist shall include on the label of such drug product dispensed pursuant to a prescription, the name of the brand name drug and the name of the generic drug. The information required pursuant to this section shall be in the following form, with the generic name and brand name inserted as appropriate: "-------_Generic for -------". L.1977, c.240, s.10; amended 2009, c.91, s.1.
NJ Rev Stat § 24:6E-10 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-10 - Signs, information to be disclosed relative to drugs, biological products to be dispensed.

24:6E-10 Signs, information to be disclosed relative to drugs, biological products to be dispensed.  11. Every pharmacy, drug store, or drug department selling prescription drugs or biological products shall post a sign at the entrance and where prescription drugs or biological products are sold disclosing the fact that upon request, before a prescription drug or biological product is dispensed, a consumer shall be told the price of such drug or biological product, whether such drug or biological product is to be substituted from a list of interchangeable drug or biological products, and of the consumer's right to be informed of the price savings resulting from substitution for such drug or biological product and to be dispensed the drug or biological product as prescribed by the physician, if not satisfied with said price savings. Such sign shall not be less than 12 inches by 12 inches. L.1977, c.240, s.11; amended 2015, c.130, s.6.
NJ Rev Stat § 24:6E-11 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-11 - Violations; penalties; collection and enforcement; validity of prescription on unauthorized form

24:6E-11. Violations; penalties; collection and enforcement; validity of prescription on unauthorized form  Any person violating any provision of this act shall be liable to a penalty of not less than $100.00 for the first offense, and not less than $200.00 for each subsequent offense. Such penalty shall be collected and enforced by summary proceedings pursuant to the Penalty Enforcement Law (N.J.S. 2A:58-1 et seq.). Process shall issue at the suit of the Board of Pharmacy or the Attorney General, and shall be either in the nature of a summons or warrant. In addition, the Board of Pharmacy may suspend or revoke the certificate of a registered pharmacist for violating any provision of this act. However, failure of the prescriber to utilize the form of prescription designated in section 8 of this act shall not invalidate the prescription as written, if said prescription is otherwise valid. L.1977, c. 240, s. 12, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-12 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-12 - Inapplicability of act to dispensation of drug permits under institutional permits

24:6E-12. Inapplicability of act to dispensation of drug permits under institutional permits  The provisions of sections 5 through 12 shall not be applicable to drug products dispensed under institutional permits when the institution involved has its own drug substitution mechanism. L.1977, c. 240, s. 13, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6E-13 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6E-13 - Severability

24:6E-13. Severability  If any provision of this act or the application thereof to any person or circumstance is held invalid, such invalidity shall not affect any other provision or application of the act which can be given effect without such invalid provision or application, and to this end the provisions of this act are declared to be severable. L.1977, c. 240, s. 14, eff. Sept. 29, 1977.
NJ Rev Stat § 24:6F-1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6F-1 - Prescribing, administering or dispensing amygdalin (laetrile); immunity of physician; written informed request; form

24:6F-1. Prescribing, administering or dispensing amygdalin (laetrile); immunity of physician; written informed request; form  No duly licensed physician shall be subject to any penalty or disciplinary action by any State agency or private professional organization solely for prescribing, administering or dispensing amygdalin, also known as laetrile or vitamin B-17, to a patient who has made a written request for such substance on the following form: WRITTEN INFORMED REQUEST FOR PRESCRIPTION OF AMYGDALIN (LAETRILE) FOR MEDICAL TREATMENT Patient's name Address Age Sex Name and address of prescribing physician Malignancy, disease, illness or physical condition diagnosed for medical treatment by amygdalin (laetrile) My physician has explained to me: (a) That the manufacture and distribution of amygdalin (laetrile) has been banned by the Federal Food and Drug Administration. (b) That neither the American Cancer Society, the American Medical Association, nor the Medical Society of New Jersey recommend use of amygdalin (laetrile) in the treatment of any malignancy, disease, illness or physical condition. (c) That there are alternative recognized treatments for the malignancy, disease, illness or physical condition from which I suffer which he has offered to provide for me including: (Here describe) That notwithstanding the foregoing, I hereby request prescription and use of amygdalin (laetrile) (a) in the medical treatment of the malignancy, disease, illness or physical condition from which I suffer [ ], or (b) as a dietary supplement [ ]. Check (a) or (b). Patient or person signing for patient Attest: Prescribing physician L.1977, c. 318, s. 1, eff. Jan. 10, 1978.
NJ Rev Stat § 24:6F-2 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6F-2 - Pharmacist; dispensing; immunity from penalty or disciplinary action; affixation of label to container

24:6F-2. Pharmacist; dispensing; immunity from penalty or disciplinary action; affixation of label to container  No duly registered pharmacist shall be subject to any penalty or disciplinary action by any State agency or private professional organization for dispensing, upon receipt of a prescription, amygdalin, provided that the pharmacist shall affix to the container containing amygdalin a label which shall contain the following statement: "Amygdalin has not been approved as a treatment or cure of any malignancy, disease, illness or physical condition by the United States Food and Drug Administration." L.1977, c. 318, s. 2, eff. Jan. 10, 1978.
NJ Rev Stat § 24:6F-3 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6F-3 - Health care facility or its employee; restriction of use; prohibition; administration or dispensing on prescription; immunity from disciplinary action or penalty

24:6F-3. Health care facility or its employee; restriction of use; prohibition; administration or dispensing on prescription; immunity from disciplinary action or penalty  No health care facility or employee thereof may restrict or forbid the use of, refuse to administer or dispense, or be subject to any disciplinary action or penalty for administering or dispensing, amygdalin, also known as laetrile or vitamin B-17, when prescribed by a physician. For the purposes of this act, "health care facility" means any such facility as defined in the "Health Care Facilities Planning Act" (C. 26:2H-1 et seq.). L.1977, c. 318, s. 3, eff. Jan. 10, 1978.
NJ Rev Stat § 24:6F-4 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6F-4 - Manufacture, introduction or delivery; immunity from liability for civil or criminal penalty

24:6F-4. Manufacture, introduction or delivery; immunity from liability for civil or criminal penalty  No person shall be held liable for any civil or criminal penalty solely for the manufacture, introduction or delivery or introduction for intrastate commerce in this State, the substance known as amygdalin, also known as laetrile or vitamin B-17; provided that such manufacture, introduction or delivery is conducted pursuant to chapters 6A and 6B of Title 24 of the New Jersey Statutes. L.1977, c. 318, s.4, eff. Jan. 10, 1978.
NJ Rev Stat § 24:6F-5 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6F-5 - Records on use; periodic studies

24:6F-5. Records on use; periodic studies  The State Department of Health shall maintain records concerning the use of the substance amygdalin, also known as laetrile or vitamin B-17, and shall make periodic studies, based on such records, concerning the efficacy of such substance in the treatment of cancer. The Commissioner of Health is hereby authorized to promulgate rules and regulations to implement the provisions of this act, including: regulations to prohibit the use of amygdalin unless such substance is prescribed by a physician on the form set out in this act; and regulations to require copies of all such forms, when completed, to be sent to the Department of Health. L.1977, c. 318, s. 5, eff. Jan. 10, 1978.
NJ Rev Stat § 24:6G-1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-1 - Control or possession without written permit; prohibition; exceptions

24:6G-1. Control or possession without written permit; prohibition; exceptions  It shall be unlawful for any person or persons, except a duly licensed physician, dentist, veterinarian, nurse, hospital, sanitarium or other medical institution, or a resident physician or intern of a hospital, sanitarium or other medical institution, to have under control or possess nitrous oxide in any form unless the person obtains a written permit issued by the Department of Health; except that no person under 19 years of age shall have under his control or possess nitrous oxide. L.1982, c. 127, s. 1, eff. Sept. 3, 1982.
NJ Rev Stat § 24:6G-2 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-2 - Sale of nitrous oxide for nonmedical use

24:6G-2. Sale of nitrous oxide for nonmedical use  2. When nitrous oxide is sold for nonmedical use, both the seller and buyer shall obtain a written permit issued by the Department of Health; except that if the seller is registered with the Department of Health as a distributor or wholesaler of nitrous oxide or if the nitrous oxide is to be used in food preparation, the seller or buyer does not have to obtain a permit. A permit shall contain the name, address and other location of the person who requests the permit and a registration number assigned by the Department of Health. The buyer shall state the intended use of the nitrous oxide on the permit.  Notwithstanding the provisions of sections 1 and 2 of this act, no person shall sell, distribute or dispense nitrous oxide to any person under 19 years of age.  L.1982,c.127,s.2; amended 1992,c.179.
NJ Rev Stat § 24:6G-3 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-3 - Record of sale; duration of retention; contents; inspection

24:6G-3. Record of sale; duration of retention; contents; inspection  Every person who sells or furnishes nitrous oxide shall retain a record of the sale for a period of 2 years. The record of the sales shall contain the name and address of the buyer, number of the buyer's permit, date of sale and amount of nitrous oxide purchased. Records shall be open to inspection by any public officer or employee engaged in the enforcement of this section. L.1982, c. 127, s. 3, eff. Sept. 3, 1982.
NJ Rev Stat § 24:6G-4 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-4 - Permits; purposes authorized

24:6G-4. Permits; purposes authorized  The Commissioner of Health is authorized to issue permits for the acquisition of nitrous oxide for the purposes enumerated in section 1 of this act. L.1982, c. 127, s. 4, eff. Sept. 3, 1982.
NJ Rev Stat § 24:6G-5 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-5 - Administration and enforcement; rules

24:6G-5. Administration and enforcement; rules  The Commissioner of Health shall administer and enforce the provisions of this act and shall issue all rules necessary to effectuate the purposes of this act. L.1982, c. 127, s. 5, eff. Sept. 3, 1982.
NJ Rev Stat § 24:6G-6 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6G-6 - Violations; penalties; recovery and enforcement

24:6G-6. Violations; penalties; recovery and enforcement  The penalties for violating any provisions of this act shall be as provided in chapter 17 of Title 24 of the Revised Statutes. Such penalties shall be recovered and enforced in the same manner and in accordance with the procedure detailed in chapter 17 of Title 24 of the Revised Statutes. In addition, any person violating the provisions of this act may be sentenced to imprisonment for a definite term which shall be fixed by the court and shall not exceed 6 months. L.1982, c. 127, s. 6, eff. Sept. 3, 1982.
NJ Rev Stat § 24:6H-1 (2021)
2021 New Jersey Revised Statutes|Title 24 - Food and Drugs|Section 24:6H-1 - Distribution of ephedrine alkaloids to minor, disorderly person; exceptions.

24:6H-1 Distribution of ephedrine alkaloids to minor, disorderly person; exceptions.  1. A person who knowingly sells, transfers or otherwise furnishes a product containing ephedrine alkaloids to a minor who is under 18 years of age is a disorderly person, unless: a. the person is a health care professional licensed pursuant to Title 45 of the Revised Statutes who has obtained consent, as required by law, to the treatment of the minor to whom the product is furnished or the parent or guardian of the minor; or b. the product is a drug as defined in R.S.24:1-1. L.2003,c.57,s.1.